Sitagliptin and Risk of Heart Failure in Patients With Type 2 Diabetes A Meta-Analysis

被引：4
|
作者：
Krittanawong, Chayakrit [1 ]
Kitai, Takeshi [1 ]
Aydar, Mehmet [1 ]
Sun, Tao [1 ]
机构：
[1] Cleveland Clin, Inst Heart & Vasc, Dept Cardiovasc Med, 9500 Euclid Ave,Desk J3-4 WT, Cleveland, OH 44195 USA
来源：
JACC-HEART FAILURE | 2016年 / 4卷 / 11期
关键词：
COHORT;
D O I：
10.1016/j.jchf.2016.07.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：910 / 910
页数：1
相关论文
共 50 条
  • [21] Effects of sitagliptin on serum lipid levels in patients with type 2 diabetes: a systematic review and meta-analysis
    Wu, Li-Da
    Zhou, Nan
    Sun, Jin-yu
    Yu, Hao
    Wang, Ru-Xing
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2022, 23 (05) : 308 - 317
  • [22] Sitagliptin and risk of heart failure hospitalization in patients with type 2 diabetes on dialysis: A population-based cohort study
    Hung, Yi-Chih
    Lin, Che-Chen
    Huang, Wei-Lun
    Chang, Man-Ping
    Chen, Ching-Chu
    SCIENTIFIC REPORTS, 2016, 6
  • [23] Meta-analysis of the risk of cataract in type 2 diabetes
    Li, Li
    Wan, Xiu-Hua
    Zhao, Guo-Hong
    BMC OPHTHALMOLOGY, 2014, 14
  • [24] Meta-analysis of the risk of cataract in type 2 diabetes
    Li Li
    Xiu-hua Wan
    Guo-hong Zhao
    BMC Ophthalmology, 14
  • [25] Sitagliptin and risk of heart failure hospitalization in patients with type 2 diabetes on dialysis: A population-based cohort study
    Yi-Chih Hung
    Che-Chen Lin
    Wei-Lun Huang
    Man-Ping Chang
    Ching-Chu Chen
    Scientific Reports, 6
  • [26] Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus A Meta-Analysis and Meta-Regression Analysis of Placebo-Controlled Randomized Clinical Trials
    Hernandez, Adrian V.
    Usmani, Ali
    Rajamanickam, Anitha
    Moheet, A.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2011, 11 (02) : 115 - 128
  • [27] Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes MellitusA Meta-Analysis and Meta-Regression Analysis of Placebo-Controlled Randomized Clinical Trials
    Adrian V. Hernandez
    Ali Usmani
    Anitha Rajamanickam
    A. Moheet
    American Journal of Cardiovascular Drugs, 2011, 11 : 115 - 128
  • [28] Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes A Network Meta-Analysis
    Kramer, Caroline K.
    Ye, Chang
    Campbell, Sara
    Retnakaran, Ravi
    JACC-HEART FAILURE, 2018, 6 (10) : 823 - 830
  • [29] Linagliptin versus sitagliptin in patients with type 2 diabetes mellitus: a network meta-analysis of randomized clinical trials
    Keshavarz, Khosro
    Lotfi, Farhad
    Sanati, Ehsan
    Salesi, Mahmood
    Hashemi-Meshkini, Amir
    Jafari, Mojtaba
    Mojahedian, Mohammad M.
    Najafi, Behzad
    Nikfar, Shekoufeh
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 25
  • [30] Effects of Sitagliptin on Lipid Profiles in Patients With Type 2 Diabetes Mellitus A Meta-analysis of Randomized Clinical Trials
    Fan, Minhua
    Li, Yuelan
    Zhang, Shihong
    MEDICINE, 2016, 95 (02)
12345